Details of the Drug Reposition

General Information of This Drug (ID: DMH0I9N)

Drug Name
YW327.6S2   DMH0I9N
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Preclinical Indication(s)
Indication Name Indication ID ICD-11 Status REF
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Preclinical [1]
Breast cancer DIS7DPX1 2C60-2C65 Preclinical [1]
------------------------------------------------------------------------------------

References

1 AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications. Mol Cancer. 2019 Nov 4;18(1):153.